
Although not statistically significant, the reduction represents a potential new pathway for treating patients with STEMI.

Gregg Stone, MD, is the director of academic affairs for the Mount Sinai Heart Health System and professor of medicine (cardiology) and of population health sciences and policy at the Icahn School of Medicine at Mount Sinai.

Although not statistically significant, the reduction represents a potential new pathway for treating patients with STEMI.